CH647749A5 - Salze und ester von monacolin-k, verfahren zu ihrer herstellung und pharmazeutische praeparate. - Google Patents
Salze und ester von monacolin-k, verfahren zu ihrer herstellung und pharmazeutische praeparate. Download PDFInfo
- Publication number
- CH647749A5 CH647749A5 CH5736/80A CH573680A CH647749A5 CH 647749 A5 CH647749 A5 CH 647749A5 CH 5736/80 A CH5736/80 A CH 5736/80A CH 573680 A CH573680 A CH 573680A CH 647749 A5 CH647749 A5 CH 647749A5
- Authority
- CH
- Switzerland
- Prior art keywords
- monacolin
- monascus
- sank
- salts
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
- C07C59/46—Unsaturated compounds containing hydroxy or O-metal groups containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9581479A JPS5621594A (en) | 1979-07-27 | 1979-07-27 | Mb-530b carboxylic acid metal salt and its preparation |
| JP12346179A JPS5646841A (en) | 1979-09-26 | 1979-09-26 | Mb-530b carboxylic acid ester and its preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH647749A5 true CH647749A5 (de) | 1985-02-15 |
Family
ID=26436995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH5736/80A CH647749A5 (de) | 1979-07-27 | 1980-07-25 | Salze und ester von monacolin-k, verfahren zu ihrer herstellung und pharmazeutische praeparate. |
Country Status (16)
| Country | Link |
|---|---|
| AT (1) | AT375334B (no) |
| AU (1) | AU6083980A (no) |
| CH (1) | CH647749A5 (no) |
| DD (1) | DD153827A5 (no) |
| DE (1) | DE3028284A1 (no) |
| DK (1) | DK322380A (no) |
| ES (1) | ES8105781A1 (no) |
| FI (1) | FI71300C (no) |
| FR (1) | FR2462417A1 (no) |
| GB (1) | GB2055100A (no) |
| IT (1) | IT1147763B (no) |
| NL (1) | NL8004303A (no) |
| NO (1) | NO156210C (no) |
| NZ (1) | NZ194445A (no) |
| PL (1) | PL225901A1 (no) |
| SE (1) | SE445828B (no) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1327360C (en) * | 1983-11-14 | 1994-03-01 | William F. Hoffman | Oxo-analogs of mevinolin-like antihypercholesterolemic agents |
| EP0164049B1 (en) * | 1984-06-04 | 1990-12-12 | Merck & Co. Inc. | Process for preparing hmg-coa reductase inhibtors with a 3,5-dihydroxypentanoate subunit |
| EP0204287A3 (en) * | 1985-06-04 | 1987-07-01 | Merck & Co. Inc. | Process for the preparation of hmg-coa reductase inhibitors with a 3,5-dihydroxypentanoate subunit |
| US4611081A (en) * | 1985-07-05 | 1986-09-09 | Merck & Co., Inc. | Process for the preparation of HMG-CoA reductase inhibitors intermediates |
| USRE33033E (en) * | 1985-07-05 | 1989-08-22 | Merck & Co., Inc. | Process for the preparation of HMG-CoA reductase inhibitors intermediates |
| US7238348B2 (en) | 1996-09-30 | 2007-07-03 | Beijing Peking University Wbl Corporation Ltd. | Method of treatment of osteoporosis with compositions of red rice fermentation products |
| US6046022A (en) | 1996-09-30 | 2000-04-04 | Peking University | Methods and compositions employing red rice fermentation products |
| JP2002518448A (ja) * | 1998-06-24 | 2002-06-25 | メルク エンド カムパニー インコーポレーテッド | 高血中コレステロールを治療する組成物および方法 |
| SI20070A (sl) | 1998-09-18 | 2000-04-30 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Nove soli inhibitorjev HMG-CoA reduktaze |
| US6806290B2 (en) | 2000-06-09 | 2004-10-19 | Lek Pharmaceuticals D.D. | Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same |
| US6531507B1 (en) * | 2000-06-09 | 2003-03-11 | Lek Pharmaceuticals D.D. | Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same |
| AU2001288724A1 (en) * | 2000-09-06 | 2002-03-22 | Merck & Co., Inc. | Dihydroxy open-acid salt of simvastatin |
| CZ200450A3 (cs) | 2001-06-13 | 2004-05-12 | Ranbaxyálaboratoriesálimited | Methylové analogy simvastatinu jako například nové inhibitory HMG@CoA reduktázy |
| KR100379075B1 (en) | 2002-03-07 | 2003-04-08 | Jinis Biopharmaceuticals Co | Method for producing low cholesterol animal food product and food product therefrom |
| US8158362B2 (en) | 2005-03-30 | 2012-04-17 | Decode Genetics Ehf. | Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype |
| CN101659923B (zh) * | 2008-08-26 | 2011-10-26 | 北京北大维信生物科技有限公司 | 一种制备开环式洛伐他汀的方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4137322A (en) * | 1976-11-02 | 1979-01-30 | Sankyo Company Limited | ML-236B carboxylic acid derivatives and their use as antihyperlipemic agents |
| JPS55150898A (en) * | 1979-05-11 | 1980-11-25 | Sankyo Co Ltd | Preparation of a new physiologically active substance mb-530b |
-
1980
- 1980-07-24 ES ES493726A patent/ES8105781A1/es not_active Expired
- 1980-07-25 CH CH5736/80A patent/CH647749A5/de not_active IP Right Cessation
- 1980-07-25 DE DE19803028284 patent/DE3028284A1/de active Granted
- 1980-07-25 FR FR8016452A patent/FR2462417A1/fr active Granted
- 1980-07-25 NZ NZ194445A patent/NZ194445A/en unknown
- 1980-07-25 NO NO802244A patent/NO156210C/no unknown
- 1980-07-25 FI FI802357A patent/FI71300C/fi not_active IP Right Cessation
- 1980-07-25 DK DK322380A patent/DK322380A/da not_active Application Discontinuation
- 1980-07-25 SE SE8005386A patent/SE445828B/sv not_active IP Right Cessation
- 1980-07-26 PL PL22590180A patent/PL225901A1/xx unknown
- 1980-07-27 NL NL8004303A patent/NL8004303A/nl not_active Application Discontinuation
- 1980-07-28 IT IT68211/80A patent/IT1147763B/it active
- 1980-07-28 AT AT0392380A patent/AT375334B/de not_active IP Right Cessation
- 1980-07-28 GB GB8024665A patent/GB2055100A/en not_active Withdrawn
- 1980-07-28 DD DD80222916A patent/DD153827A5/de unknown
- 1980-07-28 AU AU60839/80A patent/AU6083980A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ATA392380A (de) | 1983-12-15 |
| DD153827A5 (de) | 1982-02-03 |
| IT8068211A0 (it) | 1980-07-28 |
| NO156210C (no) | 1987-08-12 |
| SE445828B (sv) | 1986-07-21 |
| FR2462417B1 (no) | 1984-01-20 |
| DK322380A (da) | 1981-01-28 |
| NO802244L (no) | 1981-01-28 |
| SE8005386L (sv) | 1981-01-28 |
| AU6083980A (en) | 1981-01-29 |
| FI802357A (fi) | 1981-01-28 |
| IT1147763B (it) | 1986-11-26 |
| PL225901A1 (no) | 1982-07-19 |
| NO156210B (no) | 1987-05-04 |
| AT375334B (de) | 1984-07-25 |
| ES493726A0 (es) | 1981-06-16 |
| GB2055100A (en) | 1981-02-25 |
| ES8105781A1 (es) | 1981-06-16 |
| NZ194445A (en) | 1984-07-06 |
| DE3028284C2 (no) | 1990-08-09 |
| DE3028284A1 (de) | 1981-02-19 |
| NL8004303A (nl) | 1981-01-29 |
| FI71300C (fi) | 1986-12-19 |
| FI71300B (fi) | 1986-09-09 |
| FR2462417A1 (fr) | 1981-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3242849C2 (no) | ||
| CH645891A5 (de) | Verfahren zur herstellung von monacolin k. | |
| DE3006216C2 (de) | Monacolin K, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel | |
| DE2634499C2 (de) | Tylosin-Acylderivate, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende pharmazeutische Zubereitungen und Tierfutterzubereitungen | |
| DE2524355A1 (de) | Physiologisch aktive verbindungen und verfahren zu ihrer herstellung | |
| CH647749A5 (de) | Salze und ester von monacolin-k, verfahren zu ihrer herstellung und pharmazeutische praeparate. | |
| DE60003424T2 (de) | Hydroxylierung von compactin zu pravastatin unter verwendung von micromonospora bakterien | |
| DE4320023A1 (de) | Holotyp-Stamm Aspergillus obscurus und Verfahren zur Herstellung von µ,£-Di-(hydroxy)-7-[1,2,6,7,8,8a-hexa-(hydro)-2,6-di-(methyl)-8-(2'-{methyl}-butyryloxy)-naphthalin-1-yl]-heptansäure-£-lacton{Mevinolin} und/oder µ,5-Di-(hydroxy)-7-[1,2,6,7,8,8a-hexa-(hydro)-2,6-di-(methyl)-8-(2'-{mehtyl}-butyryloxy)-naphthalin-1-yl]-heptansäure | |
| DE60019898T2 (de) | Mikrobielles verfahren zur herstellung von pravastatin | |
| CH568386A5 (en) | Antifungal antibiotic A32204 prodn - by aerobic cultivation of Aspergillus nidulans var. echinulatus A32204 | |
| DE2849696A1 (de) | Verfahren zur herstellung des antibiotikums c-15003 p-3 | |
| DE2035814C3 (de) | Pleuromutilin-Derivate, Verfahren zu ihrer Herstellung und Verwendung | |
| DE3114242A1 (de) | Carbonsaeurederivate, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel | |
| DE69908569T2 (de) | Verfahren zur herstellung von fexofenadin | |
| EP0133971B1 (de) | Antibiotikum, dessen Herstellung sowie dessen Verwendung | |
| DE2209067A1 (de) | Neue Antibiotika, ihre Herstellung und die medizinischen Zusammensetzungen, die sie enthalten | |
| DD202047A5 (de) | Verfahren zur herstellung des makrolids 20-dihydro-20,23-dideoxytylonolid | |
| CH640269A5 (de) | Verfahren zur herstellung des antibiotikums c-15003 p-4. | |
| EP0482543B1 (de) | Oasomycine, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| DE3051206C2 (de) | Verfahren zur fermentativen Herstellung von Monacolin K | |
| DE3881566T2 (de) | Antitumor-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten. | |
| DE2510868C3 (de) | Nanaomycin A und Verfahren zur Herstellung der Antibiorica Nanaomycin A und Nanaomycin B | |
| DE946256C (de) | Verfahren zur Herstellung und Gewinnung eines Antibiotikums | |
| DE1518352C (de) | Basisch in 1 Stellung substituierte Xanthen oder Thioxanthendenvate und Ver fahren zu ihrer Herstellung | |
| CH664758A5 (de) | Verfahren zur herstellung von clavin-mutterkornalkaloiden. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |